New Antimitotic Agents with Activity in Multi-Drug-Resistant Cell Lines and in Vivo Efficacy in Murine Tumor Models
摘要:
During a screen for compounds that could inhibit cell proliferation, a series of new tubulin-binding compounds was identified with the discovery of oxadiazoline 1 (A-105972). This compound showed good cytotoxic activity against non-multi-drug-resistant and multi-drug-resistant cancer cell lines, but its utility in vivo was limited by a short half-life. Medicinal chemistry efforts led to the discovery of indolyloxazoline 22g (A-259745), which maintained all of the in vitro activity seen with oxadiazoline 1, but also demonstrated a better pharmacokinetic profile, and dose-dependent in vivo activity. Over a 28 day study, indolyloxazoline 22g increased the life span of tumor-implanted mice by up to a factor of 3 upon oral dosing. This compound, and others of its structural class, may prove to be useful in the development of new chemotherapeutic agents to treat human cancers.
Aromatic nitrogen scanning by
<i>ipso</i>
-selective nitrene internalization
作者:Tyler J. Pearson、Ryoma Shimazumi、Julia L. Driscoll、Balu D. Dherange、Dong-Il Park、Mark D. Levin
DOI:10.1126/science.adj5331
日期:2023.9.29
triggered C2-selective cheletropic carbon extrusion through a spirocyclic azanorcaradiene intermediate to afford the pyridine products. Because the ipso carbon of the aryl nitrene is excised from the molecule, the reaction proceeds regioselectively without perturbation of the remainder of the substrate. Applications are demonstrated in the abbreviated synthesis of a pyridyl derivative of estrone, as well
芳基片段中的氮扫描是药物发现过程中一个有价值的方面,但由于缺乏直接的碳氮(C-to-N)合成,目前的策略需要对每种吡啶基异构体进行耗时、平行、自下而上的合成。 ) 置换反应。我们报告了一种可定点芳基C-N取代反应,允许通过氮宾内化过程统一获得各种吡啶异构体。在两步一锅法中,芳基叠氮化物首先通过光化学转化为 3 H -氮杂平,然后通过螺环氮杂环二烯中间体进行氧化触发的 C2 选择性螯合碳挤出,得到吡啶产物。由于芳基氮烯的自身碳被从分子中切除,因此反应可以区域选择性地进行,而不会干扰底物的其余部分。其应用已在雌酮吡啶基衍生物的简化合成以及原型氮扫描中得到证实。
New Antimitotic Agents with Activity in Multi-Drug-Resistant Cell Lines and in Vivo Efficacy in Murine Tumor Models
作者:Bruce G. Szczepankiewicz、Gang Liu、Hwan-Soo Jae、Andrew S. Tasker、Indrani W. Gunawardana、Thomas W. von Geldern、Stephen L. Gwaltney、J. Ruth Wu-Wong、Laura Gehrke、William J. Chiou、R. Bruce Credo、Jeffery D. Alder、Michael A. Nukkala、Nicolette A. Zielinski、Ken Jarvis、Karl W. Mollison、David J. Frost、Joy L. Bauch、Yu Hua Hui、Akiyo K. Claiborne、Qun Li、Saul H. Rosenberg
DOI:10.1021/jm010231w
日期:2001.12.1
During a screen for compounds that could inhibit cell proliferation, a series of new tubulin-binding compounds was identified with the discovery of oxadiazoline 1 (A-105972). This compound showed good cytotoxic activity against non-multi-drug-resistant and multi-drug-resistant cancer cell lines, but its utility in vivo was limited by a short half-life. Medicinal chemistry efforts led to the discovery of indolyloxazoline 22g (A-259745), which maintained all of the in vitro activity seen with oxadiazoline 1, but also demonstrated a better pharmacokinetic profile, and dose-dependent in vivo activity. Over a 28 day study, indolyloxazoline 22g increased the life span of tumor-implanted mice by up to a factor of 3 upon oral dosing. This compound, and others of its structural class, may prove to be useful in the development of new chemotherapeutic agents to treat human cancers.
Conversion of Aryl Azides to Aminopyridines
作者:Sajan C. Patel、Noah Z. Burns
DOI:10.1021/jacs.2c08464
日期:2022.10.5
transformation of benzene into pyridine via nitrogeninsertion and carbon deletion. Herein, we report a protocol for the transformation of aryl azides, easily accessible from their corresponding anilines, to 2-aminopyridines using blue light and oxygen. Mechanistic studies corroborate that the arene to pyridine conversion is achieved by nitrogeninsertion into the benzene ring followed by oxidative carbon extrusion